Sanctuary Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$223M Sell
241,945
-2,189
-0.9% -$2.22M 1.2% 9
2025
Q4
$262M Buy
244,134
+7,349
+3% +$7.03M 1.43% 7
2025
Q3
$181M Buy
236,785
+2,185
+0.9% +$1.63M 1.04% 12
2025
Q2
$183M Buy
234,600
+1,631
+0.7% +$1.27M 1.13% 11
2025
Q1
$192M Sell
232,969
-2,628
-1% -$2.19M 1.35% 7
2024
Q4
$194M Sell
235,597
-11,428
-5% -$9.46M 1.23% 8
2024
Q3
$185M Buy
247,025
+20,451
+9% +$18.4M 1.17% 8
2024
Q2
$166M Buy
+226,574
New +$181M 1.21% 9

Other funds holding LLY

Sanctuary Advisors's LLY Position: Q1 2026 in Review

Sanctuary Advisors reduced its Eli Lilly (LLY) stake by 0.9% in Q1 2026, selling an estimated $2.22M and leaving 241,945 shares worth $223M. The position accounts for 1.2% of the portfolio, ranked #9.

Sanctuary Advisors first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $262M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sanctuary Advisors held 241,945 shares of Eli Lilly worth $223M as of Q1 2026.
  • Sanctuary Advisors sold 2,189 Eli Lilly shares in Q1 2026, an estimated $2.22M.
  • Eli Lilly made up 1.2% of Sanctuary Advisors's portfolio in Q1 2026, its #9 holding.
  • Sanctuary Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • Sanctuary Advisors's Eli Lilly position peaked at $262M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.